ARCHIVES

Avastin improves lung cancer survival, opens options for new combinations. Details of Avastin risk vs. benefit to be released at ASCO annual meeting.

This article is from The Cancer Letter archive.

Vol. 31 No. 13 | April 1, 2005

Download PDF Visit The Full Archive

Related Articles

HHS Carcinogen Guidelines Draft

June 13, 1980

Cancer Groups Criticize FDA For Ignoring Expert Advice.

November 24, 2000

GAO Recommends Tighter Policies on NIH Recusals.

June 29, 2007

Special Issue: Broder Resigns NCI To Take Job With Drug Company IVAX

December 22, 1994

OPR Reinstates Duke Medical Center’s License To Conduct Human Studies

May 28, 1999

NIH Selects 16 Clinical Centers for Women’s Health Initiative

April 9, 1993